CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Grant or award Director acquired 14,624 shares (grant or award)
- 4 Open-market buy Director bought 910,000 shares at $5.45 ($4,959,318)
- 4 Open-market buy Director bought 150,000 shares at $5.35 ($801,900)
- 4 Open-market buy SVP, Chief Medical Officer bought 3,000 shares at $5.59 ($16,755)
- 4 Open-market buy President and CEO bought 10,000 shares at $5.34 ($53,370)
- 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 7,170 shares at $6.00 ($43,020)
- 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 7,170 shares at $5.50 ($39,435)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, Chief Medical Officer sold 2,555 shares at $4.70 ($12,006)
- 4 Open-market sale Sr. VP, Drug Development sold 6,844 shares at $4.70 ($32,187)
- 4 Open-market sale VP, Fin. and Admin., CFO sold 4,397 shares at $4.70 ($20,662)
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 1,136,363 shares at $4.40 ($4,999,997)
- 4 Open-market buy Director bought 11,059 shares at $3.95 ($43,727)
- 4 Open-market buy Director bought 8,844 shares at $3.96 ($35,024)
Page 21 of 29 · 564 filings